Nami Surgical announced today that it appointed Nikki Palfrey as CEO and completed its latest investment round.

Pro-Dex stock analysis: powered surgical instruments maker with heavy customer concentration risk. Read here for more on PDEX ...

The government has proposed new rules for the nation's transplant system that aim to increase use of certain donated organs ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

ISRG heads into Q4 earnings with 18% procedure growth and da Vinci 5 demand, but valuation and tariffs keep the earnings ...

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.53 per share, beating the Zacks Consensus Estimate of $2.25 per share. This compares to earnings of $2.21 per share a year ago.

The latest update is out from SS Innovations International ( ($SSII) ). On January 6, 2026, SS Innovations announced it had completed development ...

The bullish case for the stock remains strong.

Most headphone upgrades are incremental. You get a little more bass, a little more clarity, and you move on. Open-back planar ...

The Company ended the fourth quarter of 2025 with $9.03 billion in cash, cash equivalents, and investments, an increase of $0.60 billion during the quarter, primarily driven by cash generated from ...

The December in-vivo lab builds on Vicarious Surgical's disciplined, specification-driven development approach and reflects the company's focus on minimizing technical risk through iterative testing, ...

Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...